Emerging Therapeutic Targets in Noninfectious Uveitis and Scleritis - Takeaways - MDSpire

Emerging Therapeutic Targets in Noninfectious Uveitis and Scleritis

  • By

  • Tungsattayathitthan, Usanee

  • Goldstein, Debra A

  • Janetos, Timothy M

  • April 30, 2026

  • 0 min

Share

  • 1

    Non-infectious uveitis and scleritis significantly contribute to visual disability.

  • 2

    Current treatment options for these conditions remain limited and targeted.

  • 3

    Exploration of various immunologic pathways is underway to improve treatment.

  • 4

    Targeted therapies have the potential to enhance visual prognosis for patients.

  • 5

    The review highlights promising interventions and identifies research gaps.

Original Source(s)

Emerging Therapeutic Targets in Noninfectious Uveitis and Scleritis

  • by Tungsattayathitthan, Usanee , Goldstein, Debra A, Janetos, Timothy M

  • April 30, 2026

Related Content

A New Scoring System Developed for Rabbit Models of Endotoxin-Induced Uveitis: Effective, Sensitive, and Consistent

Impact of Anti-TNF α Treatment on Persistent Non-Infectious Uveitis in Children in Saudi Arabia

Smoking Doubles Risk of Vision Loss

New research indicates smoking doubles the risk of multiple sight-threatening conditions

  • May 15, 2026

  • 3 min